CHELSEA DEWAARD: Open Payments
NPI 1497264063 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 26 payments from 14 companies in 2025. Trend: 2023 $13 · 2024 $136 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 7 | $128 |
| Calliditas Therapeutics US Inc. | 3 | $81 |
| SCPHARMACEUTICALS INC. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| NxStage Medical, Inc. | 1 | $19 |
Products named: TARPEYO, FUROSCIX, Fabhalta, JARDIANCE, IBSRELA, Kerendia, FABRAZYME, EVKEEZA.
Industry payments across SD — which companies pay providers there.
